ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
HCNorth88
|
537 |
206K |
14 |
29/06/24 |
29/06/24 |
ASX - By Stock
|
537
|
206K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
HCNorth88
|
231 |
68K |
10 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
231
|
68K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
ASH2023 - Sheba 2.0
|
|
HCNorth88
|
156 |
52K |
39 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
156
|
52K
|
39
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
HCNorth88
|
450 |
151K |
2 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
450
|
151K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
HCNorth88
|
450 |
151K |
3 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
450
|
151K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race 2022 AGM Presentations
|
|
HCNorth88
|
118 |
32K |
9 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
118
|
32K
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: 50% recruitment reached for Phase II prostate cancer trial
|
|
HCNorth88
|
25 |
11K |
6 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
25
|
11K
|
6
|
|
ASX - By Stock
|
CXM |
Re:
Nutrien
|
|
HCNorth88
|
28 |
7.4K |
9 |
21/10/22 |
21/10/22 |
ASX - By Stock
|
28
|
7.4K
|
9
|
|
ASX - By Stock
|
SIS |
Re:
General Discussion
|
|
HCNorth88
|
44 |
17K |
6 |
30/09/22 |
30/09/22 |
ASX - By Stock
|
44
|
17K
|
6
|
|
ASX - By Stock
|
CXM |
Re:
Ann: Key Appointments at Ardmore for Sales and Shipping
|
|
HCNorth88
|
19 |
5.6K |
0 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
19
|
5.6K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
HCNorth88
|
2.2K |
767K |
17 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
2.2K
|
767K
|
17
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
HCNorth88
|
2.2K |
767K |
1 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
2.2K
|
767K
|
1
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Final Director's Interest Notice
|
|
HCNorth88
|
87 |
27K |
1 |
05/09/22 |
05/09/22 |
ASX - By Stock
|
87
|
27K
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HCNorth88
|
22K |
7.6M |
4 |
05/09/22 |
05/09/22 |
ASX - By Stock
|
22K
|
7.6M
|
4
|
|
ASX - By Stock
|
SIS |
Re:
Ann: Response to ASX Price Query
|
|
HCNorth88
|
27 |
9.0K |
0 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
27
|
9.0K
|
0
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
HCNorth88
|
44K |
21M |
3 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
44K
|
21M
|
3
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
HCNorth88
|
44K |
21M |
4 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
44K
|
21M
|
4
|
|
ASX - By Stock
|
ADN |
Re:
JM 50mins
|
|
HCNorth88
|
136 |
58K |
6 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
136
|
58K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
HCNorth88
|
2.2K |
767K |
23 |
30/05/22 |
30/05/22 |
ASX - By Stock
|
2.2K
|
767K
|
23
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Investor Presentation - Shareholder Webinar
|
|
HCNorth88
|
410 |
162K |
3 |
08/04/22 |
08/04/22 |
ASX - By Stock
|
410
|
162K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
HCNorth88
|
76 |
27K |
20 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
76
|
27K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
HCNorth88
|
2.9K |
1.0M |
14 |
24/01/22 |
24/01/22 |
ASX - By Stock
|
2.9K
|
1.0M
|
14
|
|
ASX - By Stock
|
MEP |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
HCNorth88
|
11 |
2.1K |
3 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
11
|
2.1K
|
3
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
HCNorth88
|
44K |
21M |
6 |
06/12/21 |
06/12/21 |
ASX - By Stock
|
44K
|
21M
|
6
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
HCNorth88
|
44K |
21M |
5 |
06/12/21 |
06/12/21 |
ASX - By Stock
|
44K
|
21M
|
5
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Annual General Meeting Chair's Address
|
|
HCNorth88
|
232 |
68K |
2 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
232
|
68K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Share Purchase Plan Opens
|
|
HCNorth88
|
557 |
163K |
3 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
557
|
163K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Trading Halt
|
|
HCNorth88
|
218 |
67K |
5 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
218
|
67K
|
5
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
HCNorth88
|
44K |
21M |
45 |
30/09/21 |
30/09/21 |
ASX - By Stock
|
44K
|
21M
|
45
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Andromeda Progresses HPA Strategy
|
|
HCNorth88
|
163 |
53K |
2 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
163
|
53K
|
2
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
HCNorth88
|
44K |
21M |
14 |
20/09/21 |
20/09/21 |
ASX - By Stock
|
44K
|
21M
|
14
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
HCNorth88
|
44K |
21M |
1 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
44K
|
21M
|
1
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
HCNorth88
|
44K |
21M |
11 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
44K
|
21M
|
11
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
HCNorth88
|
44K |
21M |
0 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
44K
|
21M
|
0
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
HCNorth88
|
44K |
21M |
6 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
44K
|
21M
|
6
|
|
ASX - By Stock
|
MEP |
Re:
MEP
|
|
HCNorth88
|
279 |
77K |
1 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
279
|
77K
|
1
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
HCNorth88
|
44K |
21M |
2 |
15/07/21 |
15/07/21 |
ASX - By Stock
|
44K
|
21M
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Notification regarding unquoted securities - RAC
|
|
HCNorth88
|
60 |
14K |
17 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
60
|
14K
|
17
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
HCNorth88
|
11K |
4.0M |
3 |
22/06/21 |
22/06/21 |
General
|
11K
|
4.0M
|
3
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
HCNorth88
|
44K |
21M |
3 |
21/05/21 |
21/05/21 |
ASX - By Stock
|
44K
|
21M
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Trading Halt
|
|
HCNorth88
|
368 |
129K |
9 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
368
|
129K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Initiates Heart Safety Preclinical Study for Bisantrene
|
|
HCNorth88
|
176 |
56K |
6 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
176
|
56K
|
6
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
HCNorth88
|
44K |
21M |
1 |
14/04/21 |
14/04/21 |
ASX - By Stock
|
44K
|
21M
|
1
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Carbon Capture from Halloysite-Derived Nanomaterials
|
|
HCNorth88
|
176 |
64K |
3 |
14/04/21 |
14/04/21 |
ASX - By Stock
|
176
|
64K
|
3
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
HCNorth88
|
44K |
21M |
16 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
44K
|
21M
|
16
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
HCNorth88
|
22K |
7.6M |
16 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
22K
|
7.6M
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Preclinical Bisantrene Breast Cancer Results
|
|
HCNorth88
|
222 |
57K |
5 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
222
|
57K
|
5
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
HCNorth88
|
44K |
21M |
12 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
44K
|
21M
|
12
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
HCNorth88
|
44K |
21M |
2 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
44K
|
21M
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene data published in European Journal of Haematology
|
|
HCNorth88
|
60 |
16K |
5 |
10/11/20 |
10/11/20 |
ASX - By Stock
|
60
|
16K
|
5
|
|